Search research articles
Contact Us
Filters
Showing results (1-10 of 74) with videos related to
Page
of 8
Sort By:
Journal of the Royal Society of Medicine
|
February 2, 2002
11 September and after
E Scott Sills
Minerva Obstetrics and Gynecology
|
February 2, 2022
Why might ovarian rejuvenation fail? Decision analysis of variables impacting reproductive response after autologous platelet-rich plasma
E Scott Sills
Aging Medicine (Milton (N.S.W))
|
March 21, 2022
Ovarian recovery via autologous platelet-rich plasma: New benchmarks for condensed cytokine applications to reverse reproductive aging
E Scott Sills
Journal of the Royal Society of Medicine
|
March 2, 2005
Conjoined twins, delivery and the memory of medicine
E Scott Sills
Medicines (Basel, Switzerland)
|
July 2, 2021
The Scientific and Cultural Journey to Ovarian Rejuvenation: Background, Barriers, and Beyond the Biological Clock
E Scott Sills
International Journal of Health Care Quality Assurance
|
May 5, 2017
A decade of health assessments in Appalachia
E Scott Sills, Xiang Li
Bioscience Reports
|
May 17, 2019
Autologous activated platelet-rich plasma injection into adult human ovary tissue: molecular mechanism, analysis, and discussion of reproductive response
E Scott Sills, Samuel H Wood
The New England Journal of Medicine
|
November 6, 2002
Major birth defects after assisted reproduction
E Scott Sills, Gianpiero D Palermo
Reproduction & Fertility
|
October 18, 2022
Epigenetics, ovarian cell plasticity, and platelet-rich plasma: Mechanistic theories
E Scott Sills, Samuel H Wood
Global Medical Genetics
|
June 16, 2022
Phenotype from <i>SAMD9</i> Mutation at 7p21.2 Appears Attenuated by Novel Compound Heterozygous Variants at <i>RUNX2</i> and <i>SALL1</i>
E Scott Sills, Samuel H Wood
Page
of 8
Search research articles
Search
Showing results (1-10 of 74) with videos related to
Sort By:
Page
of 8
Journal of the Royal Society of Medicine
|
February 2, 2002
11 September and after
E Scott Sills
Minerva Obstetrics and Gynecology
|
February 2, 2022
Why might ovarian rejuvenation fail? Decision analysis of variables impacting reproductive response after autologous platelet-rich plasma
E Scott Sills
Aging Medicine (Milton (N.S.W))
|
March 21, 2022
Ovarian recovery via autologous platelet-rich plasma: New benchmarks for condensed cytokine applications to reverse reproductive aging
E Scott Sills
Journal of the Royal Society of Medicine
|
March 2, 2005
Conjoined twins, delivery and the memory of medicine
E Scott Sills
Medicines (Basel, Switzerland)
|
July 2, 2021
The Scientific and Cultural Journey to Ovarian Rejuvenation: Background, Barriers, and Beyond the Biological Clock
E Scott Sills
International Journal of Health Care Quality Assurance
|
May 5, 2017
A decade of health assessments in Appalachia
E Scott Sills, Xiang Li
Bioscience Reports
|
May 17, 2019
Autologous activated platelet-rich plasma injection into adult human ovary tissue: molecular mechanism, analysis, and discussion of reproductive response
E Scott Sills, Samuel H Wood
The New England Journal of Medicine
|
November 6, 2002
Major birth defects after assisted reproduction
E Scott Sills, Gianpiero D Palermo
Reproduction & Fertility
|
October 18, 2022
Epigenetics, ovarian cell plasticity, and platelet-rich plasma: Mechanistic theories
E Scott Sills, Samuel H Wood
Global Medical Genetics
|
June 16, 2022
Phenotype from <i>SAMD9</i> Mutation at 7p21.2 Appears Attenuated by Novel Compound Heterozygous Variants at <i>RUNX2</i> and <i>SALL1</i>
E Scott Sills, Samuel H Wood
Page
of 8